Literature DB >> 1571196

Genetic variation of simian immunodeficiency viruses in nonhuman primates.

P R Johnson1, V M Hirsch.   

Abstract

The generation of biologically active proviral DNA clones of simian immunodeficiency virus (SIV) that give rise to infectious virions has allowed the detailed examination of genetic variation in experimentally inoculated monkeys. Studies of nucleotide sequences derived directly from circulating leukocytes of infected monkeys show that the SIV genome undergoes rapid and dramatic variation during the course of infection. The env gene is a major site for variation, and within the Env protein, hypervariable regions analogous to those previously defined for the human immunodeficiency virus type 1 (HIV-1) env gene are apparent. A major exception is the region corresponding to the V3 domain in HIV-1, which has been highly conserved in all SIV studies to date. These data notwithstanding, the role of SIV genetic variation in the pathogenesis of AIDS in monkeys remains unclear. Genetic variation within the env gene does not appear to be sufficient for the development of AIDS since significant variation is observed in both pathogenic and nonpathogenic SIV infections. Furthermore, although it generally is believed that env gene variation might allow HIV and SIV to avoid recognition and elimination by host immune responses, this premise has not been rigorously proven. The use of molecularly cloned SIV in monkey models has provided important quantitative and qualitative information on in vivo sequence variation, and these data, in turn, have laid the groundwork for addressing the undoubtedly complex functional significance of this variation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1571196     DOI: 10.1089/aid.1992.8.367

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  8 in total

1.  Slower evolution of human immunodeficiency virus type 1 quasispecies during progression to AIDS.

Authors:  E L Delwart; H Pan; H W Sheppard; D Wolpert; A U Neumann; B Korber; J I Mullins
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  Complete inhibition of SIVmac replication by its capsid mutants.

Authors:  R Shimano; R Inubushi; K Amano; T Ogasawara; H Akari; A H Koyama; M Kawamura; A Adachi
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

3.  Gag-Pol region determines the tropism of SIVagm for human cells.

Authors:  R Shimano; R Inubushi; K Amano; T Ogasawa; A Adachi
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

4.  Bovine leukemia virus, an animal model for the study of intrastrain variability.

Authors:  L Willems; E Thienpont; P Kerkhofs; A Burny; M Mammerickx; R Kettmann
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

5.  Variability of the env gene in cynomolgus macaques persistently infected with human immunodeficiency virus type 2 strain ben.

Authors:  T Tolle; H Petry; B Bachmann; G Hunsmann; W Lüke
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

6.  CCR6 functions as a new coreceptor for limited primary human and simian immunodeficiency viruses.

Authors:  Salequl Islam; Nobuaki Shimizu; Sheikh Ariful Hoque; Atsushi Jinno-Oue; Atsushi Tanaka; Hiroo Hoshino
Journal:  PLoS One       Date:  2013-08-29       Impact factor: 3.240

7.  CKR-L3, a deletion version CCR6-isoform shows coreceptor-activity for limited human and simian immunodeficiency viruses.

Authors:  Salequl Islam; Katsuaki Kanbe; Nobuaki Shimizu; Takahiro Ohtsuki; Atsushi Jinno-Oue; Atsushi Tanaka; Hiroo Hoshino
Journal:  BMC Infect Dis       Date:  2014-07-01       Impact factor: 3.090

8.  Broad coverage of neutralization-resistant SIV strains by second-generation SIV-specific antibodies targeting the region involved in binding CD4.

Authors:  Hugh C Welles; Hannah A D King; Leonard Nettey; Nicole Cavett; Jason Gorman; Tongqing Zhou; Yaroslav Tsybovsky; Renguang Du; Kaimei Song; Richard Nguyen; David Ambrozak; Amy Ransier; Chaim A Schramm; Nicole A Doria-Rose; Adrienne E Swanstrom; James A Hoxie; Celia LaBranche; David C Montefiori; Daniel C Douek; Peter D Kwong; John R Mascola; Mario Roederer; Rosemarie D Mason
Journal:  PLoS Pathog       Date:  2022-06-16       Impact factor: 7.464

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.